Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Oral amyloidosis: A case report and diagnostic algorithm
Monoclonal Light Chains in Multiple Myeloma: The Sinister Immunoglobulin
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases - ScienceDirect
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Myeloma Explained | Haematology | Oncology | onthewards
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice - ScienceDirect
Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016
Make the Free Light Change - Siemens Healthineers USA
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis
Paraproteins and response assessments - ppt video online download
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
UHL GP NEWS
An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases - ScienceDirect
View of Screening for diabetic nephropathy: take your blinkers off | British Journal of Diabetes
Concurrent Polycythemia of Undetermined Etiology and Smouldering Plasma Cell Myeloma
Measuring M-Protein SPEP, UPEP Tests | Int'l Myeloma Fdn
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Myeloma Explained | Haematology | Oncology | onthewards
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
